Biotechnology Market size to exceed USD 775 billion by 2024

1
Biotechnology Market size to exceed USD 775
billion by 2024 Global Market Insights Inc.
Fuel Cell Market size worth 25.5bn by 2024
2
Key Insights from Biotechnology Market

• Global biotechnology market size will reach USD
  775.20 billion by 2024, increasing from USD
  330.36 billion in 2015.
• Tissue engineering and regeneration market share
  grabbed revenue of over 30 owing to increased
  prevalence rates of diabetes, Parkinsons and
  Alzheimers.
• Biopharmacy and Bioservices formed the largest
  application segment together contributing to over
  87 of industry revenue. The largest share can be
  attributed to the growing prevalence of chronic
  diseases globally, growing demand for
  personalized medicines, and increased government
  fundings.

3
Continued...

• Ethical issues pertaining to clinical trials and
  risks associated with GM organisms and crops will
  be a cause of concern. Genetically modified
  organismss uncontrolled nature can create a
  havoc to the human society and lack of proper
  regulations in most countries will further
  aggravate this problem.
• With largest geriatric population base, China and
  India will be the major revenue pockets of the
  APAC region, while Brazil and Mexico are the
  revenue pullers for LATAM.

4
U.S. Biotechnology Market Size, by Application,
2012- 2024 (USD Million)

5

Browse Full Market Research Report On
Biotechnology Market _at_ http//bit.ly/2dDO322
Request for a Sample of this Research Report
_at_ https//www.gminsights.com/request-sample/detail
/784 https//www.gminsights.com/request-sample/de
tail/49
6
360 Analysis

• Product Analysis
• Based on technology, the industry is segmented
  into tissue engineering and regeneration,
  fermentation, PCR, nanobiotechnology,
  chromatography, DNA sequencing and cell based
  assay. In 2015, the tissue engineering and
  regeneration segment accounted for highest
  revenue and was valued at over USD 104.5 billion.
  However, the nanobiotechnology, fermentation and
  cell based assay segments will experience
  lucrative growth owing to rising RD initiatives
  by various biotechnological and pharmaceutical
  companies.
• Regional Analysis
• North America dominated the revenue share in 2015
  with over USD 137.4 billion owing to growing RD
  initiatives by key industry players and rising
  awareness among public and private research
  institute.
• Competitive Market Share
• Major industry players are Abbott, Amgen,
  AstaZeneca, Biogen, Celgene, Genzyme, Johnson
  Johnson, Pfizer, GlaxoSmithKline, Genentech, F.
  Hoffman La Roche, Novartis, Lonza and Sanofi.

7
Stay In Touch Website www.gminsights.com Soci
al Media